USPTO Seeking to Leverage Artificial Intelligence to Assist with Patent Examination
By Joseph M. Hallman
In a world where the use of artificial intelligence (AI) is becoming more prevalent by the day, the United States Patent and Trademark Office (USPTO) is planning to utilize AI for patent examination purposes. On June 4, 2025, the USPTO published a Request for Information (RFI) via SAM.gov, which is the System for Award Management and […]
Continue Reading →
USPTO Accelerates Patent Grants: What Applicants Need to Know
By Melissa M. Mitchell
As of May 13, 2025, the United States Patent and Trademark Office has accelerated the time between issue notification and issue date to approximately 2 weeks from a previous average of 3 weeks. The USPTO states that expedited issuance has been made possible through elimination of administrative redundancies and by the electronic grant (eGrant) system. […]
Continue Reading →
Celebrating Innovation: The 2025 National Inventors Hall of Fame Inductees
By Kirk M. Hartung
The National Inventors Hall of Fame (NIHF) was founded in 1973 in partnership with the United States Patent and Trademark Office. It has inducted more than 600 inventors who have created great technological innovations which have benefited all phases of life. NIHF honors the past with stories of ingenuity and invention and invests in future […]
Continue Reading →
Is it time for examination by request at the USPTO?
By Charles P. Romano, Ph.D.
When the first inventor to file (FITF) provision of the America Invents Act AIA became effective in 2013, US patent law was only in part harmonized with patent law in most other Patent Cooperation Treaty (PCT) countries. One important difference between the US and many other PCT countries is that US patent examination fees are due […]
Continue Reading →
Updates on Unitary Patent and Unified Patent Court Utilization in Europe – Part 2
By Jill N. Link, Pharm.D.
We previously provided an overview of the Unitary Patent as an option to replace the national validation process of a granted Europe patent for participating member states, as well as some commentary on the utilization of the Unitary Patent since its June 1, 2023 inception. In this post, the role of the Unified Patent Court […]
Continue Reading →
Bar Associations Support the Rule of Law
By Kirk M. Hartung
The American Bar Association (ABA), in response to Executive orders and comments from elected representatives, has publicly stated on at least three occasions its general support for the rule of law, the legal profession, and an independent judiciary. The ABA is a voluntary bar organization with over 400,000 lawyer members, which represent approximately 25% of […]
Continue Reading →
Updates on Unitary Patent and Unified Patent Court Utilization in Europe – Part 1
By Jill N. Link, Pharm.D.
If you have sought international patent protection in the last two years, you have likely received information about Unitary Patents and the Unified Patent Court in Europe. If not, let me introduce you to the Unitary Patent and the Unified Patent Court. The Unitary Patent became an option for validations of a European patent upon […]
Continue Reading →
Legislative Attempts to Limit Federal Court Injunctions
By Kirk M. Hartung
Iowa’s Chuck Grassley, the longest sitting Senator in Congress (44 years) and chair of the Senate Judiciary Committee, commented on recent federal court injunctions relating to Presidential executive orders. In part, Grassley states that there is a “bipartisan problem of universal injunctions.” He further asserted that “in most cases, an injunction should only be against […]
Continue Reading →
MVS Helps Guide Drake Law Students to Washington D.C.
By Nicholas J. Krob
At McKee, Voorhees & Sease (MVS), we take immense pride in contributing to the growth of the legal profession by mentoring and supporting the next generation of attorneys. One way we do this is by coaching the Drake Law School Intellectual Property Moot Court Team. This year, Mike Gilchrist and Nick Krob had the honor […]
Continue Reading →
Patent Panic Button: Why CRISPR Titans are Revoking Their Own Patents
By Cassie J. Edgar
Gene editing technology has revolutionized molecular biology, offering unprecedented precision in genetic modifications and a lighter regulatory pathway compared to conventional transgenic approaches. However, the intellectual property landscape surrounding CRISPR has historically been overshadowed with disputes and unexpected developments. A recent and notable twist is the self-revocation of two seminal European patents by the team led by […]
Continue Reading →